Kaur, S.P.; Talat, A.; Karimi-Sari, H.; Grees, A.; Chen, H.W.; Lau, D.T.Y.; Catana, A.M.
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg). J. Clin. Med. 2022, 11, 1126.
https://doi.org/10.3390/jcm11041126
AMA Style
Kaur SP, Talat A, Karimi-Sari H, Grees A, Chen HW, Lau DTY, Catana AM.
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg). Journal of Clinical Medicine. 2022; 11(4):1126.
https://doi.org/10.3390/jcm11041126
Chicago/Turabian Style
Kaur, Satinder P., Arslan Talat, Hamidreza Karimi-Sari, Andrew Grees, Hao Wei Chen, Daryl T. Y. Lau, and Andreea M. Catana.
2022. "Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)" Journal of Clinical Medicine 11, no. 4: 1126.
https://doi.org/10.3390/jcm11041126
APA Style
Kaur, S. P., Talat, A., Karimi-Sari, H., Grees, A., Chen, H. W., Lau, D. T. Y., & Catana, A. M.
(2022). Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg). Journal of Clinical Medicine, 11(4), 1126.
https://doi.org/10.3390/jcm11041126